ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Covetrus Integrates Prescription and Practice Management Technologies

Digital scripts drive health, growth and wellness for busy veterinary clinics

Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced an enhancement to their leading practice management software to help today’s veterinary clinics compete online and deliver more complete healthcare.

The latest AVImark® and eVetPractice® updates include streamlined prescribing through an embedded integration with the Covetrus Prescription Management Platform. With access to digital scripts within these central operating systems, veterinary teams will save time, empower compliance and run more efficient and successful practices.

As veterinarians compete with aggressive online retailers focused on disintermediating their business, an integrated prescription process gives practice teams a smarter workflow that drives patient health by proactively recommending the right medication at the right time. With pet and horse owners increasingly reliant on 24/7 online shopping, veterinarians and their teams are spending hours reviewing prescription requests from online retailers, further overwhelming busy clinics and diverting resources needed to provide exceptional patient care. Digital scripts direct animal owners to the practice’s own online pharmacy, for wellness-focused workflows and faster fulfillment.

“Covetrus is committed to providing solutions that advance animal health and this integration brings together powerful technology to drive a healthier, more complete care experience,” said Georgia Wraight, executive vice president and president of Covetrus Global Technology Solutions. “Seamless digital prescriptions within practice management further supports clinics challenged by both capacity and compliance.”

The continued integration between signature Covetrus software solutions is based on significant customer feedback, user research and beta testing. Other benefits of this combined technology include the ability to create scripts from the patient record, search the full product catalog, and track prescriptions with writeback functionality.

“This integration is very simple and intuitive, which saves us time by making the prescription creation workflow much faster,” said Jennifer Potts, hospital manager at Chimney Hills Animal Hospital. “With the information embedded in our software, it’s easy to compare products and write a prescription recommendation in just a few quick steps. All of this makes our delivery of care quicker and more convenient for our pet owners, too.”

Covetrus is committed to providing powerful, integrated solutions that advance animal health and pet parent happiness. Veterinary practitioners ensure animals enjoy a high quality of life, and they deserve easier ways to reclaim their time and protect the relationships that elevate both patient wellness and practice success. To learn more about AVImark® and eVetPractice® and Covetrus integrations, please visit https://softwareservices.covetrus.com/ or join us at booth #2304 at VMX 2021.

About Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine with more than 5,500 employees serving over 100,000 customers around the globe. For more information about Covetrus visit https://covetrus.com/.

Forward-Looking Statements

This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.